10. Cancers attributable to exposure to hormones in the UK in 2010

This publication has 28 references indexed in Scilit:

• Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen
  International Journal of Cancer, 2010
• Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin
  Cancer, 2009
• Active and passive smoking and the risk of breast cancer in women aged 36–45 years: a population based case–control study in the UK
  British Journal of Cancer, 2007
• Ovarian cancer and hormone replacement therapy in the Million Women Study
  The Lancet, 2007
• Breast cancer and hormone-replacement therapy: the Million Women Study
  The Lancet, 2003
• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
  The Lancet, 1996
• Age-related factors in cancers of the breast, ovary, and endometrium
  Journal of Chronic Diseases, 1987